Hot Business News Today VIR Q4 Earnings Beat on Higher Revenues From Covid Treatment by Zacks Equity Research • February 25, 2022 • 0 Comments VIR beat earnings estimates in the fourth quarter on higher sotrovimab revenues for COVID-19 patients. Read more...
